Stockscreener 앱 받기
56.03
0.25%
-0.14
전일 마감가:
$56.17
열려 있는:
$56.41
하루 거래량:
1.53M
Relative Volume:
0.57
시가총액:
$8.77B
수익:
$1.21B
순이익/손실:
$109.52M
주가수익비율:
80.48
EPS:
0.6962
순현금흐름:
$269.60M
1주 성능:
+2.98%
1개월 성능:
+29.40%
6개월 성능:
-2.45%
1년 성능:
+8.52%
1일 변동 폭
$55.53
$56.96
1주일 범위
$51.97
$56.96
52주 변동 폭
$43.20
$72.16
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
612-379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
56.03 | 8.79B | 1.21B | 109.52M | 269.60M | 0.6962 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-07-09 | 개시 | TD Cowen | Buy |
| 2025-05-30 | 개시 | Wells Fargo | Overweight |
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
Bio-Techne (TECH) Stock Valuation After New Refeyn Bispecific Antibody Analysis Collaboration - Yahoo Finance
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne (TECH) Gains 4% as Activist Investor Pushes for Strat - GuruFocus
Bio-Techne gains on report activist investor Ananym pushing for sale - Seeking Alpha
Bio-Techne stock rises as activist pushes for sale By Investing.com - Investing.com India
Activist Investor Ananym Urges Bio-Techne to Consider Selling - Bloomberg
Piper Sandler Launches Coverage on Bio-Techne (TECH), Prefers Patience on Sector Growth Drivers - Insider Monkey
Why is Techne (TECH) up 4.5% since last earnings report? - MSN
Is Bio-Techne Corporation (TECH) A Good Stock To Buy Now? - Yahoo Finance
Bio-Techne Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
TECH Initiates Coverage On Bio-Techne -- Price Target Announced at $65 - GuruFocus
Piper Sandler initiates Bio-Techne stock with neutral rating By Investing.com - Investing.com Nigeria
Piper Sandler initiates Bio-Techne stock with neutral rating - Investing.com
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
New Bispecific Antibody Characterization Workflow Might Change The Case For Investing In Bio-Techne (TECH) - Yahoo Finance
Bio-Techne Corp (TECH) Stock Analysis: Exploring a Potential 18% Upside and Strong Buy Ratings - DirectorsTalk Interviews
Bio-Techne Corporation Trade Ideas — XETR:TE1 - TradingView
ETFs Investing in Bio-Techne Corporation Stocks - TradingView
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
Bio-Techne (TECH) Slips 2.3% as Life Sciences Sector Faces HeadwindsImbalance Zone - newsline.com
Why Is Techne (TECH) Up 4.5% Since Last Earnings Report? - Yahoo Finance
BIO-TECHNE (TECH) executive reports RSU exercise, tax withholding and corrected holdings - Stock Titan
Bio?Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization - Investing News Network
Bio-Techne and Refeyn launch workflow for antibody analysis By Investing.com - Investing.com India
Bio-Techne and Refeyn launch workflow for antibody analysis - Investing.com
New 4-hour test links charge and size in bispecific antibodies and biosimilars - Stock Titan
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
How Bio-techne Corp (TECH) Affects Rotational Strategy Timing - Stock Traders Daily
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
Bio-Techne Corp (TECH) Stock Analysis: Exploring A Potential 18.84% Upside - DirectorsTalk Interviews
TECH Stock Price, Quote & Chart | BIO-TECHNE CORP (NASDAQ:TECH) - ChartMill
Bio-Techne (TECH) Shows Modest Upside as Shares Rebound from SupportCumulative Volume - newsline.com
Are Wall Street analysts bullish on Bio-Techne stock? - MSN
Bio-Techne (TECH) Gains 2.28% as Shares Approach Resistance ZoneRisk Parity Rebalance - newsline.com
Q1 2026 Bio-Techne Corp Earnings Call Transcript - GuruFocus
TECH Q1 2026 Earnings: EPS Misses Estimates Amid Mixed Demand SignalsPost-Earnings Drift - The Legal Advocate
Bio-Techne stock hits 52-week low at 46.04 USD By Investing.com - Investing.com Nigeria
Bio-Techne Corp (TECH) Gains Ground, Approaches Key Resistance LevelsTriple MA Cross - thelegaladvocate.com
Are Wall Street Analysts Bullish on Bio-Techne Stock? - inkl
Bio-Techne Corp (TECH) Stock Analysis: An Investor's Look At 27% Potential Upside - DirectorsTalk Interviews
Bio-Techne (TECH) Q1 2026 Earnings: EPS Misses Estimates but Shares Edge HigherAnnual Financial Report - thelegaladvocate.com
Bio-Techne Stock Is Rebounding — But One Weak Spot Could Decide the Next Move - Bez Kabli
Bio-Techne Corp (TECH) Stock Analysis: Unlocking a 41.84% Upside Potential in Healthcare Innovation - DirectorsTalk Interviews
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call - Yahoo Finance
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
바이오-테크네 주식 (TECH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director |
May 08 '26 |
Sale |
48.28 |
6,636 |
320,386 |
200 |
1.27%
1.43%
자본화:
|
볼륨(24시간):